TLR3 and triple-negative breast carcinoma: Similarly, exosomes modified with α-lactalbumin (α-LA) delivered human neutrophil elastase (ELANE) and the Toll-like receptor 3 (TLR3) agonist Hiltonol, both inducers of immunogenic cell death, to triple-negative breast cancer (TNBC) models.